Preclinical Safety evaluation services of drug

Category:

Booth No: M320

Characteristic

LBI preclinical testing center complies with international ICH, US FDA, European EMA, and other relevant regulations, and has passed USFDA GLP inspection, European GLP working group audit, and Japan PMDA GLP inspection, providing stable and consistent data quality.
LBI preclinical testing center can provide drug safety assessment, including general toxicity, genotoxicity, reproductive and developmental toxicity, safety pharmacology, etc. Whether it is a non-GLP or GLP test, the following items are the services:
- Pharmacokinetic/toxicokinetic study (PK/TK)
- Bio distribution assay
- General Toxicology
single dose
repeat dose
- Genotoxicology
- Safety Pharmacology
- Reproductive toxicology
- Immunotoxicology
-Customized service
Xenograft tumor model
Cytokine profile analysis
Biomarker analysis
Immunohistochemistry analysis

Other Products

Biocompatibility test services of medical device

Highest Rated Products

Back

Menu

Preclinical Safety evaluation services of drug

Characteristic

Other Products

Highest Rated Products